Comparing two MRI-guided biopsy methods for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial compares two ways to use MRI images during a prostate biopsy to see which finds cancer better. It looks at 'fusion' biopsy (where a computer combines MRI with live ultrasound) versus 'cognitive' biopsy (where the doctor mentally matches the MRI to the ultrasound).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man scheduled for a prostate biopsy as part of your normal care
- This is your first prostate biopsy, or you have not had one in the past 3 years
- You had a special MRI (mp-MRI) that showed one or more spots rated PIRADS 3, 4, or 5 (areas that might be cancer)
- The largest spot on the MRI is 2 cm or smaller
- Your PSA level is 20 or lower, or an exam found something abnormal
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to guide a prostate biopsy using MRI images, to see which better detects clinically significant prostate cancer in men with suspicious MRI findings.
This trial compares two ways to take a prostate biopsy (through the rectum or through the skin between the scrotum and anus) to see which is more accurate. Men with suspicious MRI findings (PI-RADS 3, 4, or 5) who haven't had prostate cancer before may be eligible.
This trial compares two ways to guide a prostate biopsy for men with abnormal MRI findings. It may help if you have never had a prostate biopsy and have certain PSA levels.
This study compares two ways of doing prostate biopsies (sampling tissue from the prostate) to see if one is better. It is for men who have a suspicious MRI finding on one side of the prostate and have not had a biopsy before. Participation may help determine which method is more accurate and could influence future care.
This trial compares two ways of taking prostate biopsies to see which is more accurate at detecting cancer. Both use MRI images to guide the biopsy, which may help find cancer more precisely.
This study tests whether an artificial intelligence tool for MRI can improve the results of targeted prostate biopsy, compared to the usual method. It could help diagnose prostate cancer more accurately with fewer needles.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.